Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
4.740
-0.090 (-1.86%)
Dec 5, 2025, 4:00 PM EST - Market closed
Cellectis Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Cellectis stock has a target of 8.00, which predicts an increase of 68.78% from the current stock price of 4.74.
Analyst Consensus: Buy
* Price targets were last updated on Oct 17, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Cellectis is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $4 → $8 | Buy | Maintains | $4 → $8 | +68.78% | Oct 17, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | -15.61% | May 13, 2025 |
| Barclays | Barclays | Buy Maintains $7 → $5 | Buy | Maintains | $7 → $5 | +5.49% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $11 → $10 | Buy | Maintains | $11 → $10 | +110.97% | Jun 12, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +26.58% | May 31, 2024 |
Financial Forecast
Revenue This Year
65.25M
from 49.22M
Increased by 32.58%
Revenue Next Year
62.38M
from 65.25M
Decreased by -4.40%
EPS This Year
-0.94
from -0.41
EPS Next Year
-1.18
from -0.94
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 78.6M | 92.7M | ||||
| Avg | 65.3M | 62.4M | ||||
| Low | 39.2M | 29.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 59.8% | 42.0% | ||||
| Avg | 32.6% | -4.4% | ||||
| Low | -20.4% | -54.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.66 | -0.90 | |
| Avg | -0.94 | -1.18 | |
| Low | -1.46 | -1.59 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.